Caxton Associates (New York)’s Celanese CE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,501
Closed -$316K 469
2022
Q3
$316K Sell
3,501
-5,444
-61% -$598K 0.04% 317
2022
Q2
$1.05M Buy
+8,945
New +$1.28M 0.1% 115
2020
Q3
Sell
-4,104
Closed -$354K 337
2020
Q2
$354K Sell
4,104
-3,457
-46% -$288K 0.03% 208
2020
Q1
$555K Buy
+7,561
New +$748K 0.1% 137
2018
Q4
Sell
-8,667
Closed -$988K 305
2018
Q3
$988K Sell
8,667
-55,761
-87% -$6.39M 0.07% 146
2018
Q2
$7.16M Buy
64,428
+61,938
+2,487% +$6.83M 0.36% 53
2018
Q1
$250K Sell
2,490
-7,406
-75% -$781K 0.01% 303
2017
Q4
$1.06M Buy
9,896
+4,796
+94% +$510K 0.05% 203
2017
Q3
$532K Buy
+5,100
New +$501K 0.02% 321
2016
Q4
Sell
-110,000
Closed -$7.32M 218
2016
Q3
$7.32M Buy
+110,000
New +$7.19M 0.25% 68

Other funds holding CE

Caxton Associates (New York)'s CE Position: Q4 2022 in Review

Caxton Associates (New York) sold out of Celanese (CE) in Q4 2022, closing a stake of 3,501 shares — an estimated $316K sold.

Caxton Associates (New York) first reported a position in CE in Q3 2016 and held it in 10 quarters. The position peaked at $7.32M in Q3 2016. 649 funds tracked by Wall St. Rank hold CE as of Q4 2022.

  • Caxton Associates (New York) reported no remaining Celanese position as of Q4 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 3,501 Celanese shares in Q4 2022, an estimated $316K.
  • Caxton Associates (New York) first reported a position in Celanese in Q3 2016 and held it in 10 quarters.
  • Caxton Associates (New York)'s Celanese position peaked at $7.32M in Q3 2016.
  • 649 funds tracked by Wall St. Rank held Celanese as of Q4 2022.

Based on Caxton Associates (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.